Overview
Hafsat Mashegu is a Hematologist and an Oncologist practicing medicine in Tulsa, Oklahoma.
Her clinical expertise encompasses Marginal Zone Lymphoma (MZL), Sickle Cell Disease, Hepatic Venoocclusive Disease with Immunodeficiency, and Congenital Hemolytic Anemia.
She is actively involved in clinical research, co-authoring 4 peer reviewed articles and participating in 2 clinical trials.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
Locations
4502 E 41st St, Tulsa, OK 74135
3401 Civic Center Blvd, Philadelphia, PA 19104
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Saint Francis Cancer Center
Jihad Khattab is a Hematologist and an Oncologist practicing medicine in Tulsa, Oklahoma. Dr. Khattab is highly rated in 45 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Large-Cell Lung Carcinoma. Dr. Khattab is currently accepting new patients.
Saint Francis Cancer Center
Muhammad Janjua is a Hematologist and an Oncologist practicing medicine in Tulsa, Oklahoma. Dr. Janjua is highly rated in 49 conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Familial Pancreatic Cancer, Aplastic Anemia, Immune Thrombocytopenic Purpura (ITP), and Bone Marrow Aspiration. Dr. Janjua is currently accepting new patients.
Oklahoma Cancer Specialists & Research Institute
Christopher M. Manus, MD, is an independent medical oncologist and hematologist at Ascension St. John in Bartlesville, Oklahoma. Dr. Manus diagnoses and treats adults with cancer and focuses on managing care during and after chemotherapy, radiation therapy and surgery. Every appointment with Dr. Manus starts with a conversation. He takes the time to answer all your questions — big and small. Dr. Manus is highly rated in 77 conditions, according to our data. His clinical expertise encompasses Lynch Syndrome, Colorectal Cancer, Familial Colorectal Cancer, and Paget Disease of the Breast. Dr. Manus is board certified in The American Board Of Internal Medicine - Hematology, The American Board Of Internal Medicine - Hospice And Palliative Medicine, The American Board Of Internal Medicine - Medical Oncology, and The American Board Of Internal Medicine - Internal Medicine. Dr. Manus is currently accepting new patients.
Frequently Asked Questions about Dr. Hafsat U. Mashegu
How do I make an appointment with Dr. Hafsat U. Mashegu?
You can book an appointment with Dr. Hafsat U. Mashegu by calling their office at 918-660-3416. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Hafsat U. Mashegu a top-rated expert for Marginal Zone Lymphoma (MZL)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Hafsat U. Mashegu is classified as an Experienced expert for Marginal Zone Lymphoma (MZL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Hafsat U. Mashegu specialize in?
While Dr. Hafsat U. Mashegu is a Hematology, they have specific expertise in Marginal Zone Lymphoma (MZL), Sickle Cell Disease, and Hepatic Venoocclusive Disease with Immunodeficiency. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Hafsat U. Mashegu participate in research or clinical trials?
Yes. Dr. Hafsat U. Mashegu has published 4 articles and abstracts on conditions like Marginal Zone Lymphoma (MZL). You can view a list of Dr. Hafsat U. Mashegu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Hafsat U. Mashegu accept my insurance?
Dr. Hafsat U. Mashegu accepts most major insurance plans, including Aetna and Health Care Services Corporation. We recommend calling the office directly at 918-660-3416 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- AnemiaDr. Mashegu isExperienced. Learn about Anemia.
- Congenital Hemolytic AnemiaDr. Mashegu isExperienced. Learn about Congenital Hemolytic Anemia.
- Follicular LymphomaDr. Mashegu isExperienced. Learn about Follicular Lymphoma.
- HemoglobinopathyDr. Mashegu isExperienced. Learn about Hemoglobinopathy.
- Hemolytic AnemiaDr. Mashegu isExperienced. Learn about Hemolytic Anemia.
- Hepatic Venoocclusive Disease with Immunodeficiency
- Marginal Zone Lymphoma (MZL)Dr. Mashegu isExperienced. Learn about Marginal Zone Lymphoma (MZL).
- Sickle Cell DiseaseDr. Mashegu isExperienced. Learn about Sickle Cell Disease.